Mylan updates efforts regarding COVID-19; hydroxychloroquine sulfate tablets production volume increased
Mylan's hydroxychloroquine sulfate tablets are currently approved by the FDA for the treatment of malaria, lupus erythematosus and rheumatoid arthritis.